Indiana Code
Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders
16-41-17-10. Follow-Up Programs; Newborn Screening Fees; Waste Blood Specimen Confidentiality

Sec. 10. (a) The state department shall develop the following:
(1) A registry for tracking and follow-up of all newborns and individuals for screening.
(2) A centralized program that provides follow-up, diagnosis, management, and family counseling and support, including equipment, supplies, formula, and other materials, for all infants and individuals identified as having one (1) of the disorders listed in section 2 of this chapter.
(3) A laboratory quality assurance program, including proficiency testing.
(4) A statewide network of genetic evaluation and counseling services.
(5) A system for using, for epidemiological survey and research purposes, any waste blood specimen generated under this chapter.
(b) The program described in subsection (a) shall be funded by collection of a newborn screening fee for each newborn screened by a designated laboratory.
(c) The state department shall set the fee and procedures for disbursement under rules adopted under IC 4-22-2. The fee must be based upon the projected cost of the program. The proposed fee must be approved by the budget agency before the rule is adopted.
(d) The designated laboratory shall assess, collect, and deposit the fees established under subsection (c) in the newborn screening fund established under section 11 of this chapter.
(e) The state department shall annually review the newborn screening fee.
(f) Waste blood specimens used for the purpose of implementing the system described under subsection (a)(5) may not include the name or other identifying characteristics that would identify the individual submitting the specimen.
[Pre-1993 Recodification Citation: 16-8-6-8 part.]
As added by P.L.2-1993, SEC.24.

Structure Indiana Code